Description
Used in the treatment of:
- Non-Hodgkin’s Lymphoma (NHL)
- Chronic Lymphocytic Leukemia (CLL)
- Rheumatoid arthritis (in combination therapy)
Rituximab is a monoclonal antibody directed against CD20 antigen on B-lymphocytes, causing targeted cell destruction.



